Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Videos | Structural Heart Occluders

John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the ...

Home November 08, 2017
Home
Videos | Cath Lab

Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on ...

Home November 08, 2017
Home
News | Heart Valve Technology

November 8, 2017 —  Medtronic plc recently presented new clinical research to support the positive clinical performance ...

Home November 08, 2017
Home
Videos | Heart Valve Technology

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home November 08, 2017
Home
Videos | Heart Valve Technology

Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the ...

Home November 08, 2017
Home
Harpoon Mitral Valve Repair System data reported at TCT 2017
Feature | Heart Valve Technology

November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and can ...

Home November 07, 2017
Home
Videos | Heart Valve Technology

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of ...

Home November 07, 2017
Home
News | Heart Valve Technology

November 7, 2017 — Medtronic plc recently presented positive data for its self-expanding Intrepid transcatheter mitral ...

Home November 07, 2017
Home
News | Heart Valve Technology

November 7, 2017 — A new study has found that a pioneering device to repair heart valves is safe and effective, and can ...

Home November 07, 2017
Home
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab

November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found no ...

Home November 06, 2017
Home
News | Heart Valve Technology

November 6, 2017 — One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System ...

Home November 06, 2017
Home
News | Wearables

November 3, 2017 — VitalConnect Inc. announced the fourth and final Series C closing, bringing the total Series C round ...

Home November 03, 2017
Home
The Watchman LAA occluder PREVAIL Trial 5-year results were presented at the 2017 TCT meeting.
Feature | Atrial Fibrillation

November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...

Home November 02, 2017
Home
News | Heart Valve Technology

November 1, 2017 — Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found transcatheter ...

Home November 01, 2017
Home
News | Heart Valve Technology

October 31, 2017 — Edwards Lifesciences Corp. announced new data demonstrating substantial economic advantages of the ...

Home October 31, 2017
Home
Subscribe Now